JNJ vs MELI: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and MercadoLibre, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Johnson & Johnson · Healthcare
$238.46
-11.8% upside to fair value
Med Conviction
Grade C+
VS
MercadoLibre, Inc. · Consumer Cyclical
$1,767.42
+41.4% upside to fair value
High Conviction
Grade A
QuantHub Verdict
MELI has more upside to fair value
(+41.4%).
JNJ trades at a lower forward P/E
(20.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
MELI |
| Current Price |
$238.46 |
$1,767.42 |
| Fair Value Estimate |
$210.28 |
$2,500.00 |
| Upside to Fair Value |
-11.8%
|
+41.4%
|
| Market Cap |
$574.7B |
$89.6B |
| Forward P/E |
20.2x
|
35.0x
|
| EV / EBITDA |
13.3x
|
18.5x
|
| Price / Sales |
6.2x
|
3.1x
|
| Price / FCF |
29.4x
|
8.9x
|
| Revenue Growth YoY |
+6.1%
|
+39.1%
|
| Gross Margin |
72.8%
|
44.5%
|
| Operating Margin |
27.2%
|
11.1%
|
| Return on Equity |
32.87%
|
33.7%
|
| Dividend Yield |
2.18% |
0% |
| FCF Yield |
3.4%
|
12.1%
|
| Analyst Consensus |
Moderate Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a high-quality healthcare conglomerate focused exclusively on Innovative Medicine and MedTech following the Kenvue spin-off. The company delivered $94.2B in FY2025 revenue with 6% operational growth, generated $19.7B in free cash flow, and guided for $99.5-100.5B in 2026 operational sales (above consensus). However, at $238 the stock trades at a P/S of 6.15x, well above the 5…
MercadoLibre is the dominant e-commerce and fintech ecosystem across Latin America, operating the largest marketplace and digital payments platform in a region with 670M+ people where e-commerce penetration is still under 15%. Revenue grew 39% to $28.9B in FY2025 with $10.8B in free cash flow — a 12% FCF yield at current prices. The company is trading at its 5-year P/S minimum (3.1x) and P/FCF mi…
Accumulation Zones
| Metric |
JNJ |
MELI |
| Zone Low |
$157.71 |
$1,875.00 |
| Zone High |
$178.74 |
$2,125.00 |
| In Buy Zone? |
No
|
Yes
|